Tilt Investment Management Holdings’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$618K Sell
2,144
-10,749
-83% -$2.93M 0.67% 35
2023
Q3
$3.47M Hold
12,893
2.47% 4
2023
Q2
$2.86M Hold
12,893
1.89% 4
2023
Q1
$3.05M Buy
12,893
+361
+3% +$88.6K 2.26% 4
2022
Q4
$3.29M Buy
+12,532
New +$3.36M 2.79% 4

Other funds holding AMGN

Tilt Investment Management Holdings's AMGN Position: Q4 2023 in Review

Tilt Investment Management Holdings reduced its Amgen (AMGN) stake by 83% in Q4 2023, selling an estimated $2.93M and leaving 2,144 shares worth $618K. The position accounts for 0.67% of the portfolio, ranked #35.

Tilt Investment Management Holdings first reported a position in AMGN in Q4 2022 and has held it in 5 quarters since. The position peaked at $3.47M in Q3 2023. 2,717 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Tilt Investment Management Holdings held 2,144 shares of Amgen worth $618K as of Q4 2023.
  • Tilt Investment Management Holdings sold 10,749 Amgen shares in Q4 2023, an estimated $2.93M.
  • Amgen made up 0.67% of Tilt Investment Management Holdings's portfolio in Q4 2023, its #35 holding.
  • Tilt Investment Management Holdings first reported a position in Amgen in Q4 2022 and has held it in 5 quarters since.
  • Tilt Investment Management Holdings's Amgen position peaked at $3.47M in Q3 2023.
  • 2,717 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q4 2023, filed 31 Jan 2024.